JGH:原发性结直肠癌术后发生第二原发性结直肠癌的危险因素分析

2022-01-27 MedSci原创 MedSci原创

大肠癌是常见的恶性肿瘤,包括结肠癌和直肠癌。大肠癌的发病率从高到低依次为直肠、乙状结肠、盲肠、升结肠、降结肠及横结肠,近年有向近端(右半结肠)发展的趋势。

      大肠癌(CRC)是世界上第二大癌症死亡原因,而大肠癌筛查可降低大肠癌死亡率。结肠镜检查是最常见的CRC筛查方法之一,因为它可以直接观察到小的肿瘤性结肠病变。然而,不必要的结肠镜检查可能是相当有害的,因为结肠镜检查的肠道准备工作可能导致脱水或电解质失衡,而且结肠镜检查可能导致结肠穿孔。

因此,关注患CRC的高风险人群是很重要的。一些风险因素已被推荐为CRC筛查的对象,如50岁以上,有CRC阳性家族史,尤其是一级亲属患有CRC的患者。尽管过去的CRC病史也是发展为第二原发性CRC的一个风险因素,但尚未确定何时或如何对第二原发性CRC进行术后监测。本项研究旨在使用风险函数分析来评估发生第二原发性 CRC 或高级别腺瘤 (HGA) 的风险率变化,以便在初次手术后有效识别第二原发性结直肠肿瘤CRC患者。

 

      为此,研究人员回顾性招募了 1823 名 0-III 期 CRC 患者,这些患者在 2004 年至 2015 年间接受了根治性手术,并在术后进行了结肠镜检查。研究人员对这些患者进行了随访评估了手术后发生异时性 CRC 和 HGA 的风险率随时间的变化。

 

      研究结果发现继发性结直肠肿瘤的危险函数曲线在术后 1.22 年到一个高峰,该曲线下降至 4年,然后趋于稳定。老年患者的风险高于年轻患者,两者均在1年达到峰值。在年轻患者中观察到另一个峰值出现在术后6和8年。男性患者的风险高于女性患者,有同步病变的患者的风险率明显高于无同步病变的患者,在术后 1 年和 9 年左右有两个明显的发病高峰。

图:直肠癌术后第二原发性肿瘤的发生率

 

      本项研究结果建议所有CRC患者在接受CRC手术后的最初 2 至 3 年内进行强化结肠镜监测,如果患者年龄在 60 岁以下并伴有 CRC 或 HGA,则还建议在术后 6 至 8 年进行更长时间的随访监测。

 

原始出处:

Kazushige Kawai. Et al. Hazard function analysis for development of second primary colorectal cancer after surgery for primary colorectal cancer. Journal of Gastroenterology and Hepatology.2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847025, encodeId=2266184e02569, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Aug 19 08:48:40 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240618, encodeId=51051240618ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bba6463073, createdName=ms2000001573454710, createdTime=Tue Aug 23 23:05:43 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189777, encodeId=df5f1189e7724, content=打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654c5385773, createdName=ms3000000949399284, createdTime=Wed Feb 02 21:21:48 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453656, encodeId=383b1453656bc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Jan 28 00:48:40 CST 2022, time=2022-01-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847025, encodeId=2266184e02569, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Aug 19 08:48:40 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240618, encodeId=51051240618ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bba6463073, createdName=ms2000001573454710, createdTime=Tue Aug 23 23:05:43 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189777, encodeId=df5f1189e7724, content=打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654c5385773, createdName=ms3000000949399284, createdTime=Wed Feb 02 21:21:48 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453656, encodeId=383b1453656bc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Jan 28 00:48:40 CST 2022, time=2022-01-28, status=1, ipAttribution=)]
    2022-08-23 ms2000001573454710

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847025, encodeId=2266184e02569, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Aug 19 08:48:40 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240618, encodeId=51051240618ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bba6463073, createdName=ms2000001573454710, createdTime=Tue Aug 23 23:05:43 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189777, encodeId=df5f1189e7724, content=打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654c5385773, createdName=ms3000000949399284, createdTime=Wed Feb 02 21:21:48 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453656, encodeId=383b1453656bc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Jan 28 00:48:40 CST 2022, time=2022-01-28, status=1, ipAttribution=)]
    2022-02-02 ms3000000949399284

    打卡

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847025, encodeId=2266184e02569, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Aug 19 08:48:40 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240618, encodeId=51051240618ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bba6463073, createdName=ms2000001573454710, createdTime=Tue Aug 23 23:05:43 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189777, encodeId=df5f1189e7724, content=打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654c5385773, createdName=ms3000000949399284, createdTime=Wed Feb 02 21:21:48 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453656, encodeId=383b1453656bc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Jan 28 00:48:40 CST 2022, time=2022-01-28, status=1, ipAttribution=)]

相关资讯

STTT:秦环龙团队发现结直肠癌中的“坏”细菌,有时可能成为特洛伊木马

梭形杆菌属(fusobacterium)由于菌体形态两端尖锐呈梭形而得名。存在于人和动物口腔、上呼吸道、肠道、泌尿系的正常菌群,以口腔居多。

Gastroenterology:含硫的饮食模式会增加早发性结直肠癌的发生风险

结肠癌是发生于结肠的恶性肿瘤,是胃肠道中常见的恶性肿瘤。国外男、女发病率差别不大,在我国男性稍多于女性,其发病率居我国恶性肿瘤的第八位。

DCR:结直肠癌手术后心肌损伤与术后90天死亡率密切相关

结肠癌是常见的发生于结肠部位的消化道恶性肿瘤,好发于直肠与乙状结肠交界处,以40~50岁年龄组发病率最高,男女之比为2~3:1。发病率占胃肠道肿瘤的第3位。

GUT: 粪便免疫化学试验筛查近端和远端结直肠癌的长期有效性分析

基于大量循证医学证据,欧盟、亚太、中国、美国等陆续确立了定量粪便潜血免疫检测(定量FIT)在结直肠癌筛查中的优先地位,是结直肠癌(CRC)筛查的重要手段。

Clin Gastroenterology H: 慢传输型便秘患者患帕金森病和结直肠癌的风险评估

老年人便秘是指排便次数减少,同时排便困难、粪便干结。正常人每日排便1~2次或1~2日排便1次,便秘患者每周排便少于3次,并且排便费力,粪质硬结、量少。便秘是老年人常见的症状,约1/3的老年人出现便秘,

Sci Adv:浙大周民团队用螺旋藻作为药物递送载体,用于结肠癌和结肠炎治疗

口服给药,是胃肠疾病治疗的首选和最常用的给药途径,主要是其具有安全性高、患者依从性高,方便和易于生产等优势。